Eric B Harstad

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Top Venues

Molecular cancer therapeutics

Toxicological sciences : an official journal of the Society of Toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Haley D Neff-LaFord, Sarah A Carratt, Christopher Carosino, Nancy Everds, Kristen A Cardinal, Steven Duniho, Melissa M Schutten, Christopher Frantz, Christina Zuch de Zafra, Eric B Harstad
The vedotin antibody-drug conjugate payload drives platform-based nonclinical safety and pharmacokinetic profiles. Molecular cancer therapeutics (2024)
Rhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, Kimberly Perkins, Glenmar P Obedencio, Andrea S Kim, Michael W Conner, David L Bourdet, Eric B Harstad
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species. Toxicological sciences : an official journal of the Society of Toxicology 186 (2) (2022)